HELICOBACTER PYLORI CAGA/VACAS1-M1 STRAIN IS ASSOCIATED WITH HIGH RISK OF FIBROSIS IN METABOLIC-DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE

被引：0
|
作者：
Barreyro, Fernando [1 ]
Maiorana, Facundo [1 ]
Neschuk, Magali [1 ]
Caronia, Maria Viriginia [1 ]
Elizondo, Karina [2 ]
Schneider, Adolfo [2 ]
Veron, Georgina [2 ]
Zapata, Pedro Dario [1 ]
机构：
[1] Natl Univ Misiones, Misiones, Argentina
[2] Barcelo Univ Inst Hlth Sci, Buenos Aires, DF, Argentina
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1200
引用
收藏
页码：S914 / S915
页数：2
相关论文
共 50 条
  • [41] Metabolic dysfunction-associated steatotic liver disease-associated fibrosis and cardiac dysfunction in patients with type 2 diabetes
    Cernea, Simona
    Onisor, Danusia
    Roiban, Andrada Larisa
    Benedek, Theodora
    Rat, Nora
    WORLD JOURNAL OF CARDIOLOGY, 2024, 16 (10):
  • [42] LIVER STIFFNESS MEASUREMENT AND HEPATOCELLULAR CARCINOMA RISK IN METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
    John, Binu
    Deng, Yangyang
    Singal, Amit
    Dahman, Bassam
    HEPATOLOGY, 2024, 80 : S768 - S769
  • [43] Exploring autoantibodies as predictors of severe fibrosis or cirrhosis in metabolic dysfunction associated steatotic liver disease
    Ragheb, Mariam
    Van Iderstine, Micah Grubert
    Minuk, Gerald
    Faisal, Nabiha
    CANADIAN LIVER JOURNAL, 2024, 7 (02): : 291 - 298
  • [44] Comparing imaging modalities in the assessment of fibrosis in metabolic dysfunction-associated steatotic liver disease
    Ravanbakhsh, Naseem
    Browne, Debra
    Weaver, Carly
    Gholikhani, Asal
    Kavarian, Patil
    Mitsinikos, Tania
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2024, 79 (06): : 1192 - 1198
  • [45] The performance of the enhanced liver fibrosis test by cardiometabolic risk factors in patients with metabolic dysfunction-associated steatotic liver disease
    Kawata, Kazuhito
    Takahashi, Hirokazu
    Arai, Taeang
    Seko, Yuya
    Chida, Takeshi
    Noritake, Hiedenao
    Toyoda, Hidenori
    Hayashi, Hideki
    Yamaguchi, Kanji
    Iwaki, Michihiro
    Yoneda, Masato
    Shima, Toshihide
    Fujii, Hideki
    Morishita, Asahiro
    Tomita, Kengo
    Kawanaka, Miwa
    Yoshida, Yuichi
    Ikegami, Tadashi
    Notsumata, Kazuo
    Oeda, Satoshi
    Atsukawa, Masanori
    Kamada, Yoshihiro
    Sumida, Yoshio
    Fukushima, Hideaki
    Miyoshi, Eiji
    Aishima, Shinichi
    Okanoue, Takeshi
    Itoh, Yoshito
    Nakajima, Atsushi
    JOURNAL OF HEPATOLOGY, 2024, 80 : S537 - S538
  • [46] Cardiometabolic phenotype linked to fibrosis and mortality in metabolic dysfunction-associated steatotic liver disease
    Dong, Rui
    Tian, Ting
    Luo, Zhenghan
    Chang, Dongchun
    Xue, Hong
    Qu, Sen
    Wang, Jia
    Shen, Chao
    Zhang, Ru
    Wang, Jie
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2025, 35 (03)
  • [47] Management of cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease
    Mellemkjaer, Anders
    Kjaer, Mikkel Breinholt
    Haldrup, David
    Gronbaek, Henning
    Thomsen, Karen Louise
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 122 : 28 - 34
  • [48] Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
    Zheng, Haixiang
    Sechi, Leonardo Antonio
    Navarese, Eliano Pio
    Casu, Gavino
    Vidili, Gianpaolo
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [49] Metabolic Dysfunction-Associated Steatotic Liver Disease: Pathogenetic Links to Cardiovascular Risk
    Ionescu, Vlad Alexandru
    Gheorghe, Gina
    Bacalbasa, Nicolae
    Diaconu, Camelia Cristina
    BIOMOLECULES, 2025, 15 (02)
  • [50] Metabolic dysfunction-associated steatotic liver disease and cancer risk: A cohort study
    Peng, Yu
    Wang, Peng
    Liu, Fubin
    Wang, Xixuan
    Si, Changyu
    Gong, Jianxiao
    Zhou, Huijun
    Gu, Jiale
    Qin, Ailing
    Song, Weijie
    Song, Fangfang
    DIABETES OBESITY & METABOLISM, 2025, 27 (04): : 1940 - 1949
12345